Trials / Completed
CompletedNCT00286910
Urinary Aquaporin 2 and Expression of the NPHS2 Gene in Adults Suffering From Nephrotic Syndrome
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Regional Hospital Holstebro · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
We want to test the hypothesises that patients with nephrotic syndrome have a higher excretion of AQP2 in the urine,that they have a higher concentration of AVP,and a lower C-H2O.Everything will normalize, when the syndrome is in remission.Furthermore we want to test the hypothesis that the expression of mutations in the NPHS2-gene,that codes for podocin,will cause a lack off or a poorer response in the treatment of nephrotic syndrome
Conditions
Timeline
- Start date
- 2005-05-01
- First posted
- 2006-02-06
- Last updated
- 2010-03-18
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00286910. Inclusion in this directory is not an endorsement.